APrf Michael O'Callaghan
School of Medicine
College of Health
Eligible to supervise Masters and PhD - email supervisor to discuss availability.
I am a clinical epidemiologist with expertise in:
- Prostate Cancer
- Urology
- Clinical Registries
- Evidence Based Medicine
| Date | Position | Institution name |
|---|---|---|
| 2020 - ongoing | Associate Professor | Flinders University |
| 2016 - ongoing | Affiliate Senior Lecturer | University of Adelaide |
| 2015 - 2020 | Affiliate Senior Lecturer | Flinders University |
| 2014 - 2016 | Visiting Research Fellow | University of Adelaide |
| 2013 - ongoing | Senior Researcher and Educator | SA Health |
| 2013 - 2016 | Honorary Affiliate Lecturer | University of Adelaide, Robinson Institute |
| 2013 - 2013 | Postdoctoral Research Fellow | University of South Australia |
| 2012 - 2013 | Postdoctoral Research Fellow | University of Adelaide |
| 2011 - 2012 | Endeavour Postdoctoral Research Fellow | University of Auckland |
| Date | Institution name | Country | Title |
|---|---|---|---|
| 2004 | University of Adelaide, Department of Physiology | Australia | Honours Degree of Science |
| 2003 | University of Adelaide, Department pf Physiology | Australia | Bachelor Degree of Science |
| Date | Title | Institution | Country |
|---|---|---|---|
| 2008 - 2011 | PhD candidate with the Discipline of Obstetrics and Gynaecology | University of Adelaide, Faculty of Health and Medical Sciences | Australia |
| Date | Title | Institution name | Country |
|---|---|---|---|
| 2019 | Statistical Practice in Epidemiology using R | University of Tartu | Estonia |
| 2018 | Postgraduate Research Supervision Program | Flinders University | Australia |
| 2018 | Good Clinical Practice | NIDA Clinical Trials Network | - |
| 2013 | Epidemiological Methods | International Epidemiological Association | China |
| 2012 | Analysis of Linked Data | Statistical Society of Australia | - |
| 2009 | Future Research Leaders Program | Go8 Universities of Australia | - |
| 2008 | Cochrane Review methods | Australasian Cochrane Centre | - |
| Year | Citation |
|---|---|
| 2025 | Tiruye, T., Jay, A., Higgs, B., O'Callaghan, M., FitzGerald, L. M., Moretti, K., . . . Beckmann, K. (2025). Comparing post‑treatment urinary and colorectal procedures in prostate cancer patients using population‑based linked data. International Urology and Nephrology, 57(4), 1189-1198. Scopus2 WoS2 Europe PMC2 |
| 2025 | Charlick, M., Ettridge, K., Tiruye, T., O'Callaghan, M., Sara, S., Jay, A., & Beckmann, K. (2025). Improving sexual well-being support for men with prostate cancer: the health professional perspective. European Journal of Cancer Care, 2025(1, article no. 2875201), 1-11. |
| 2025 | Charlick, M., Tiruye, T., Ettridge, K., O'Callaghan, M., Jay, A., & Beckmann, K. (2025). Use of erectile dysfunction treatments after prostate cancer treatment and their perceived impact on men's sex life: an analysis of patient reported outcome survey data. BMC Urology, 25(21), 1-11. Scopus1 WoS1 Europe PMC2 |
| 2025 | Tiruye, T., Jay, A., Higgs, B., O'Callaghan, M., FitzGerald, L., Moretti, K., . . . Beckmann, K. (2025). Urinary and colorectal procedures following prostate cancer treatment. BJU International, 135(S2), 98. |
| 2025 | O'Callaghan, M., Ullah, S., Smith, D., Mark, S., Clarke, J., Rouse, D., . . . Moretti, K. (2025). Predicting incontinence and erectile function after prostate cancer surgery: international validation of models. Surgical Oncology, 59, 1-6. Scopus1 WoS1 Europe PMC1 |
| 2025 | John, A., Milton, T., Gupta, A., Nguyen, M. T., Stretton, B., Hewitt, J., . . . Callaghan, M. O. (2025). Impact of positive surgical margin location after radical prostatectomy: a network meta-analysis. World Journal of Urology, 43(1), 11 pages. Scopus4 WoS4 Europe PMC3 |
| 2025 | Tempo, J., Felemban, S., Qin, K. R., Perera, M., Ischia, J., Bolton, D., . . . O’Callaghan, M. (2025). Radical cystectomy mortality in older patients: a systematic review and meta-analysis. BJU International, 136(1), 19-31. Europe PMC1 |
| 2025 | Charlick, M., Murphy, M., Murphy, B., Ettridge, K., O'Callaghan, M., Sara, S., . . . Beckmann, K. (2025). Sexual wellbeing support for men with prostate cancer: a qualitative study with patients. Translational Andrology and Urology, 14(4), 913-927. Scopus1 WoS1 Europe PMC1 |
| 2025 | O'Callaghan, M. E., Casey, M., Pearl, D., Hickey, O., Fosse, A., Sigurosson, S. E., . . . Glynn, L. (2025). COVID-19 open data: An ecological study and international collaboration examining pandemic trends in Northern Periphery arctic countries. HEALTH INFORMATICS JOURNAL, 31(2), 17 pages. |
| 2025 | Visscher, J., Bonevski, B., & O'Callaghan, M. (2025). The association of smoking with urinary and sexual function recovery following radical prostatectomy. BJU International, 136(4), 647-656. |
| 2025 | Williams, N., Remmers, S., Jay, A., Santoro, K., & O'Callaghan, M. (2025). External Validation of MRI-Based Prostate Cancer Risk Calculators in an Australian Cohort. ANZ Journal of Surgery, 95(9), 1906-1911. |
| 2025 | Tiruye, T., Jay, A., O'Callaghan, M., FitzGerald, L. M., Roder, D., & Beckmann, K. (2025). Post‑prostatectomy rehospitalisation rates and risk factors in South Australian men with prostate cancer: evidence from linked data. International Urology and Nephrology, online, 1-10. |
| 2025 | Tiruye, T., Higgs, B., O'Callaghan, M., FitzGerald, L. M., Roder, D., & Beckmann, K. (2025). Socioeconomic and Geographic Disparities in Anorectal and Urinary Procedures Following Radiotherapy for Prostate Cancer. Cancer Medicine, 14(15, article no. e71135), 1-10. Europe PMC1 |
| 2025 | Chiam, K., Bang, A., Nair-Shalliker, V., Caruana, M., Patel, M. I., Sengupta, S., . . . Smith, D. P. (2025). Treatment variations in localised prostate cancer in Australia and New Zealand: a registry study. BJU International, 136(S2), S62-S69. |
| 2025 | Oh, C., Bourlotos, G., O'Callaghan, M., Grundy, L., & Hong, M. (2025). BCG Intolerance in Nonmuscle Invasive Bladder Cancer—A Systematic Review. ANZ Journal of Surgery, 8 pages. |
| 2024 | Colditz, P. B., Boyd, R. N., Winter, L., Pritchard, M., Gray, P. H., Whittingham, K., . . . Sanders, M. R. (2024). A Randomized Trial of Baby Triple P for Preterm Infants: Child Outcomes at 2 Years of Corrected Age (vol 210, pg 48, 2019). JOURNAL OF PEDIATRICS, 275, 1 page. |
| 2024 | Harbour, E., Stanley, F., Casey, M., O'Callaghan, M., & Glynn, L. (2024). Simulated GP clinic closure: effects on patient access in the Irish Mid-West. RURAL AND REMOTE HEALTH, 24(4), 10 pages. WoS1 |
| 2024 | David, R. V., Islam, A., Miller, J., O'Callaghan, M. E., & Kahokehr, A. A. (2024). Genitourinary toxicity after pelvic radiation: Prospective review of complex urological presentations. Asian Journal of Urology, 11(4), 633-641. |
| 2024 | Ong, W. L., Krishnaprasad, K., Bensley, J., Steeper, M., Beckmann, K., Breen, S., . . . Millar, J. (2024). Population-based prostate cancer outcomes registries - what have we learned and where are we heading?. BJU International, 134(S2), 9-11. Scopus5 WoS5 Europe PMC4 |
| 2024 | Charlick, M., Tiruye, T., Ettridge, K., O'Callaghan, M., Sara, S., Jay, A., & Beckmann, K. (2024). Prostate cancer related sexual dysfunction and barriers to help seeking: a scoping review. Psycho-oncology, 33(8), 1-13. Scopus6 WoS6 Europe PMC6 |
| 2024 | Tiruye, T., Roder, D., FitzGerald, L. M., O'Callaghan, M., Moretti, K., Caughey, G. E., & Beckmann, K. (2024). Impact of comorbidities on prostate cancer‐specific mortality: A population‐based cohort study. The Prostate, 84(12), 1138-1145. Scopus10 WoS9 Europe PMC9 |
| 2024 | Tiruye, T., Hiwase, M., Charlick, M., O'Callaghan, M., Khalid, A., Li, M., . . . Beckmann, K. (2024). Temporal trends in medication and service use patterns for mental health issues among men with prostate cancer. Psychooncology, 33(7), e6369-1-e6369-11. Scopus1 WoS2 |
| 2024 | Kinnear, N., Fonseca, P. C., Ogbechie, C., Adam, S., Haidar, O., Jinaraj, A., . . . Adshead, J. (2024). Impact of frozen section on long-term outcomes in robot-assisted laparoscopic prostatectomy. BJU International, 134(4), 608-614. Scopus2 WoS2 Europe PMC3 |
| 2024 | Oh, C., & O’Callaghan, M. (2024). Seminal Papers in Urology: Darolutamide and survival in metastatic, hormone-sensitive prostate cancer. BMC Urology, 24(1), 3 pages. |
| 2024 | Tiruye, T., O'Callaghan, M., FitgGerald, L. M., Moretti, K., Jay, A., Higgs, B., . . . Beckmann, K. (2024). Medication-based comorbidity measures and prostate cancer treatment selection. Clinical Genitourinary Cancer, 22(2), 599-609. Scopus8 WoS8 Europe PMC6 |
| 2024 | Tempo, J. A., Sii, S., Ischia, J., Bolton, D. M., D'Onise, K., Meng, R., . . . O'Callaghan, M. (2024). Lessons from a population-based bladder cancer registry: exploring why survival is not improving. BJU International, 133(6), 699-708. Scopus4 WoS3 Europe PMC4 |
| 2024 | Collingridge, A., & O’Callaghan, M. (2024). Seminal papers in urology: urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study: Borghi L, Meschi T, Amato F, Briganti A, Novarini A, Giannini A. urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. The Journal of urology. 1996 Mar;155(3):839 − 43. BMC Urology, 24(1), 4 pages. |
| 2024 | Abd Wahab, H. H. B., & O’Callaghan, M. (2024). Seminal papers in urology: two-year outcomes of Sacral Neuromodulation Versus OnabotulinumtoxinA for refractory urgency urinary incontinence: a Randomized Trial. BMC Urology, 24(1), 3 pages. Scopus1 WoS1 Europe PMC1 |
| 2024 | Visscher, J., Hiwase, M., Bonevski, B., & O’Callaghan, M. (2024). The association of smoking with urinary and sexual function recovery following radical prostatectomy for localized prostate cancer: a systematic review and meta-analysis. Prostate Cancer and Prostatic Diseases, 27(2), 222-229. Scopus9 WoS8 Europe PMC8 |
| 2024 | O'Callaghan, M., Bulamu, N., Gormly, K., & Jay, A. (2024). Re: Prevalence of MRI Lesions in Men Responding to a GP-led Invitation for a Prostate Health Check: A Prospective Cohort Study. European Urology, 85(4), 392-397. Europe PMC4 |
| 2024 | Tiruye, T., Roder, D., FitzGerald, L. M., O'Callaghan, M., Moretti, K., & Beckmann, K. (2024). Utility of prescription-based comorbidity indices for predicting mortality among Australian men with prostate cancer. Cancer Epidemiology, 88(102516), 1-7. Scopus7 WoS7 Europe PMC5 |
| 2024 | Borg, M. A., O'Callaghan, M. E., Moretti, K. L., & Vincent, A. D. (2024). External validation of predictive models of sexual, urinary, bowel and hormonal function after surgery in prostate cancer subjects. BMC Urology, 24(1), 2-1-2-8. Scopus1 WoS1 Europe PMC1 |
| 2024 | Rabinowitz, J., Kinnear, N., O’Callaghan, M., Hennessey, D., Shafi, F., Fuller, A., . . . Vasdev, N. (2024). Systematic review of the ophthalmic complications of robotic-assisted laparoscopic prostatectomy. Journal of Robotic Surgery, 18(1), 8 pages. Scopus1 WoS1 |
| 2024 | Mac Curtain, B. M., Sugrue, D. D., Qian, W., O'Callaghan, M., & Davis, N. F. (2024). Membranous urethral length and urinary incontinence following robot-assisted radical prostatectomy: a systematic review and meta-analysis. BJU International, 133(6), 646-655. Scopus10 WoS13 Europe PMC12 |
| 2024 | Tiruye, T. Y., O'Callaghan, M., Ettridge, K., Moretti, K., Jay, A., Higgs, B., . . . Beckmann, K. (2024). Clinical and functional outcomes for risk-appropriate treatments for prostate cancer. BJUI Compass, 5(1), 109-120. Scopus10 WoS10 Europe PMC7 |
| 2023 | Tiruye, T., Ettridge, K., O'Callaghan, M., Moretti, K., Jay, A., Higgs, B., . . . Beckmann, K. (2023). Reporting real-world data on prostate cancer treatment outcomes to consumers: the prostate cancer report card. European Journal of Cancer Care, 2023(6660371), 1-12. Scopus6 WoS6 |
| 2023 | Tiruye, T., Roder, D., FitzGerald, L. M., O'Callaghan, M., Morreti, K., & Beckmann, K. (2023). Prognostic value of comorbidity measures among Australian men with non-metastatic prostate cancer. Cancer Epidemiology, 87(102482), 1-6. Scopus6 WoS5 Europe PMC1 |
| 2023 | Tiruye, T., David, R., O'Callaghan, M., FitzGerald, L. M., Higgs, B., Kahokehr, A. A., . . . Beckmann, K. (2023). Risk of secondary malignancy following radiation therapy for prostate cancer. Scientific Reports, 23(20083), 1-10. Scopus15 WoS15 Europe PMC12 |
| 2023 | Alghazo, O., & O’Callaghan, M. (2023). PSMA-PET to detect prostate cancer recurrence after radiotherapy. Nature Reviews Urology, 20(1), 5-6. Scopus1 WoS1 Europe PMC1 |
| 2023 | Tiruye, T., O'Callaghan, M., Ettridge, K., Jay, A., Santoro, K., Moretti, K., & Beckmann, K. (2023). Factors impacting on sexual function among men on active surveillance for prostate cancer. The Prostate, 83(7), 678-687. Scopus10 WoS8 Europe PMC7 |
| 2023 | John, A., Lim, A., Catterwell, R., Selth, L., & O’Callaghan, M. (2023). Length of positive surgical margins after radical prostatectomy: Does size matter? – A systematic review and meta-analysis. Prostate Cancer and Prostatic Diseases, 26(4), 673-680. Scopus12 WoS13 Europe PMC13 |
| 2023 | Bulamu, N. B., Mpundu-Kaambwa, C., O'Callaghan, M., & Kaambwa, B. (2023). Responsiveness and construct validity of EPIC-26, AQoL-6D and SF-6D following treatment in prostate cancer.. BMC cancer, 23(1), 13 pages. Scopus3 WoS3 Europe PMC2 |
| 2023 | Tempo, J., Bolton, D., & O’Callaghan, M. (2023). Seminal papers in urology: maintenance Bacillus Calmette-Guerin (BCG) immunotherapy for recurrent Ta, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized southwest oncology group study (SWOG-8507). BMC Urology, 23(1), 4 pages. Scopus2 WoS2 Europe PMC1 |
| 2023 | Shugg, N., & O'Callaghan, M. E. (2023). Seminal papers in urology: anticholinergic therapy vs. onabotulinumtoxina for urgency urinary incontinence.. BMC urology, 23(1), 1-4. |
| 2023 | O' Callaghan, M. E., Roberts, M., Grummet, J., Mark, S., Gilbourd, D., Frydenberg, M., . . . Papa, N. (2023). Trends and variation in prostate cancer diagnosis via transperineal biopsy in Australia and New Zealand. Urologic Oncology Seminars and Original Investigations, 41(7), 324-324.e20. Scopus6 WoS7 Europe PMC6 |
| 2023 | O'Callaghan, M. (2023). Re: Addition of Nintedanib or Placebo to Neoadjuvant Gemcitabine and Cisplatin in Locally Advanced Muscle-invasive Bladder Cancer (NEOBLADE): A Double-blind, Randomised, Phase 2 Trial. European Urology, 84(4), 440-441. |
| 2023 | Beckmann, K. R., O'Callaghan, M. E., Vincent, A. D., Moretti, K. L., & Brook, N. R. (2023). Clinical outcomes for men with positive surgical margins after radical prostatectomy—results from the South Australian Prostate Cancer Clinical Outcomes Collaborative community-based registry. Asian Journal of Urology, 10(4), 502-511. Scopus5 WoS5 Europe PMC7 |
| 2023 | O'Callaghan, M. E., Roberts, M. J., Moretti, K. L., Frydenberg, M., Gilbourd, D., Mark, S., . . . Papa, N. (2023). Variation in patient reported outcomes following radical prostatectomy: a bi-national registry-based study. Urologic Oncology: Seminars and Original Investigations, 41(2, no. 105.e), 9-18. Scopus5 WoS4 Europe PMC4 |
| 2023 | Tempo, J., Yiu, T. W., Ischia, J., Bolton, D., & O'Callaghan, M. (2023). Global changes in bladder cancer mortality in the elderly. Cancer Epidemiology, 82, 10 pages. Scopus10 WoS9 Europe PMC7 |
| 2023 | Wei, G., Harley, F., O’Callaghan, M., Adshead, J., Hennessey, D., & Kinnear, N. (2023). Systematic review of urological injury during caesarean section and hysterectomy. International Urogynecology Journal, 34(2), 371-389. Scopus18 WoS14 Europe PMC11 |
| 2023 | Harley, F., Wei, G., O'Callaghan, M., Wong, L. M., Hennessey, D., & Kinnear, N. (2023). Xanthogranulomatous pyelonephritis: a systematic review of treatment and mortality in more than 1000 cases. BJU International, 131(4), 395-407. Scopus16 WoS18 Europe PMC22 |
| 2023 | David, R., Buckby, A., Kahokehr, A. A., Lee, J., Watson, D. I., Leung, J., & O’Callaghan, M. E. (2023). Long term genitourinary toxicity following curative intent intensity-modulated radiotherapy for prostate cancer: a systematic review and meta-analysis. Prostate Cancer and Prostatic Diseases, 26(1), 8-15. Scopus19 WoS19 Europe PMC13 |
| 2022 | Hiwase, M. D., Jay, A., Bulamu, N., Teh, J., Paterson, F., Kichenadasse, G., . . . Walsh, S. (2022). Evaluation of selective bone scan staging in prostate cancer – external validation of current strategies and decision-curve analysis. Prostate Cancer and Prostatic Diseases, 25(2), 336-343. |
| 2022 | McIntosh, M., Opozda, M. J., O’Callaghan, M., Vincent, A. D., Galvão, D. A., & Short, C. E. (2022). Why do men with prostate cancer discontinue active surveillance for definitive treatment? A mixed methods investigation. Psycho-Oncology, 31(8), 1420-1430. Scopus13 WoS13 Europe PMC12 |
| 2022 | McIntosh, M., Opozda, M. J., O'Callaghan, M., Vincent, A. D., Galvão, D. A., & Short, C. E. (2022). Impact of different unconditional monetary incentives on survey response rates in men with prostate cancer: a 2-arm randomised trial. BMC Medical Research Methodology, 22(1, article no. 252), 1-8. Scopus1 WoS1 Europe PMC1 |
| 2022 | David, R. V., Kahokehr, A. A., Lee, J., Watson, D. I., Leung, J., & O’Callaghan, M. E. (2022). Incidence of genitourinary complications following radiation therapy for localised prostate cancer. World Journal of Urology, 40(10), 2411-2422. Scopus14 WoS13 Europe PMC11 |
| 2022 | David, R., Hiwase, M., Kahokehr, A. A., Lee, J., Watson, D. I., Leung, J., & O'Callaghan, M. E. (2022). Predicting post-radiation genitourinary hospital admissions in patients with localised prostate cancer. World Journal of Urology, 40(12), 2911-2918. Scopus4 WoS5 Europe PMC3 |
| 2022 | Tiruye, T., O’Callaghan, M., Moretti, K., Jay, A., Higgs, B., Santoro, K., . . . Beckmann, K. (2022). Patient-reported functional outcome measures and treatment choice for prostate cancer. BMC Urology, 22(1), 1-11. Scopus13 WoS13 Europe PMC12 |
| 2022 | Radbone, C., Beckmann, K., Roder, D., O'Callaghan, M., Moretti, K., Fitzgerald, L., & Buckley, L. (2022). Multi-jurisdictional Prostate cancer registry linkage. International Journal of Population Data Science, 7(3, article no. 2101), 1. |
| 2022 | Chan, K. M., Gleadle, J. M., O'Callaghan, M., Vasilev, K., & MacGregor, M. (2022). Prostate cancer detection: a systematic review of urinary biosensors. Prostate Cancer and Prostatic Diseases, 25(1), 39-46. Scopus27 WoS32 Europe PMC15 |
| 2022 | Li, J. Y., Bodda, S., Jay, A., Kichenadasse, G., Chong, M., Gleadle, J. M., & O’Callaghan, M. (2022). Protocol for the Flinders Kidney Health Registry: patient outcomes of kidney cancers and nephrectomies. BMC Urology, 22(1), 8 pages. |
| 2021 | Soo, A., O'Callaghan, M. E., Kopsaftis, T., Vatandoust, S., Moretti, K., & Kichenadasse, G. (2021). PSA response to antiandrogen withdrawal: a systematic review and meta-analysis. Prostate Cancer and Prostatic Diseases, 24(3), 826-836. Scopus3 WoS4 Europe PMC3 |
| 2021 | O'Callaghan, M., Papa, N., Pase, M., Frydenberg, M., Mark, S., Moretti, K., . . . Millar, J. (2021). Patterns of care for prostate cancer treatment and improving outcomes - are national registries the answer?. BJU International, 128(S1), 6-8. Scopus12 WoS12 Europe PMC12 |
| 2021 | John, A., John, H., Catterwell, R., Selth, L. A., & Callaghan, M. O. (2021). Primary Gleason grade and Gleason grade group at positive surgical margins: a systematic review and meta-analysis. BJU International, 127(S1), 13-22. Scopus18 WoS18 Europe PMC16 |
| 2021 | Jay, A. P. M., Aldiwani, M., O'Callaghan, M. E., Pearce, A. K., Huddart, R. A., Mayer, E., . . . Nicol, D. L. (2021). Features and Management of Late Relapse of Nonseminomatous Germ Cell Tumour. European Urology Open Science, 29, 82-88. Scopus2 WoS1 Europe PMC2 |
| 2021 | Kinnear, N., Jolly, S., Herath, M., Han, J., Tran, M., O'Callaghan, M., . . . Moore, J. (2021). The acute surgical unit: An updated systematic review and meta-analysis. International Journal of Surgery, 94(October), 1-13. Scopus10 WoS11 Europe PMC8 |
| 2021 | Pryor, D. I., Martin, J. M., Millar, J. L., Day, H., Ong, W. L., Skala, M., . . . Papa, N. (2021). Evaluation of hypofractionated radiation therapy use and patient-reported outcomes in men with nonmetastatic prostate cancer in Australia and New Zealand. JAMA Network Open, 4(11, article no. 2129647), 1-12. Scopus16 WoS15 Europe PMC14 |
| 2021 | McIntosh, M., Short, C. E., O’Callaghan, M., Vincent, A. D., Galvão, D. A., & Opozda, M. J. (2021). A Mixed Methods Investigation of Unmet Needs And Psychological Wellbeing During Active Surveillance For Prostate Cancer. |
| 2020 | Lin, D., O'Callaghan, M. E., David, R., Fuller, A., Wells, R., Sutherland, P., & Foreman, D. (2020). Does urethral length affect continence outcomes following robot assisted laparoscopic radical prostatectomy (RALP)?. |
| 2020 | Kinnear, N., Barnett, D., O'Callaghan, M., Horsell, K., Gani, J., & Hennessey, D. (2020). The impact of catheter-based bladder drainage method on urinary tract infection risk in spinal cord injury and neurogenic bladder: A systematic review.. Neurology and Urodynamics, 39(2), 854-862. Scopus72 WoS64 Europe PMC45 |
| 2020 | Jones, B. C., Youlden, D. R., Cundy, T. P., O'Callaghan, M. E., Karpelowsky, J., Aitken, J. F., & McBride, C. A. (2020). Renal tumours in Australian children: 30 years of incidence, outcome and second primary malignancy data from the Australian Childhood Cancer Registry. Journal of Paediatrics and Child Health, 56(6), 908-916. Scopus5 WoS5 Europe PMC5 |
| 2020 | Lin, D., O'Callaghan, M., David, R., Fuller, A., Wells, R., Sutherland, P., & Foreman, D. (2020). Does urethral length affect continence outcomes following robot assisted laparoscopic radical prostatectomy (RALP)?. BMC Urology, 20(1), 7 pages. Scopus21 WoS20 Europe PMC15 |
| 2020 | Morias, S., Buckley, E., Beckmann, K., O'Callaghan, M., Borg, M., & Short, M. (2020). Variation in radiotherapy patterns of care in the radical treatment of South Australian men with non-metastatic prostate cancer between 2005–2015. Radiotherapy and Oncology, 145, 138-145. Scopus3 WoS3 Europe PMC2 |
| 2020 | Tempo, J., Logan, C., O'Callaghan, M., Kahokehr, A., Kichenadasse, G., D'Onise, K., & Foreman, D. (2020). Bladder, penile, renal pelvis and testis cancers: A population based analysis of incidence and survival 1977-2013. Cancer Epidemiology, 65, 8 pages. Scopus9 WoS10 Europe PMC8 |
| 2020 | John, A., O'Callaghan, M., Catterwell, R., & Selth, L. (2020). Does Gleason score of positive surgical margin after radical prostatectomy affect biochemical recurrence and oncological outcomes? Protocol for systematic review. BMJ Open, 10(3), 4 pages. Scopus4 WoS4 Europe PMC3 |
| 2020 | Kinnear, N., Herath, M., Jolly, S., Han, J., Tran, M., Parker, D., . . . Moore, J. (2020). Patient Satisfaction in Emergency General Surgery: A Prospective Cross-Sectional Study. World J Surg, 44(9), 2950-2958. Scopus6 WoS6 Europe PMC2 |
| 2020 | Ang, M., Borg, M., & O'Callaghan, M. E. (2020). Survival outcomes in men with a positive family history of prostate cancer: A registry based study. BMC Cancer, 20(1), 8 pages. Scopus20 WoS16 Europe PMC12 |
| 2020 | O'Callaghan, M., Jay, A., Kichenadasse, G., & Moretti, K. (2020). Androgen Deprivation Therapy in Unlikely to be Effective for Treatment of COVID-19.. Ann Oncol, 31(12), 1780-1782. Scopus8 WoS9 Europe PMC9 |
| 2020 | Lu, T. C., Collins, L., Cohen, P., Jay, A., Campbell, J. M., & O’Callaghan, M. (2020). Prognostic Differences in ISUP Grade Group 4: a Systematic Review and Meta-Analysis. Pathology and Oncology Research, 26(3), 1367-1375. Scopus5 WoS5 Europe PMC6 |
| 2020 | Toale, C., Westby, D., O'Callaghan, M., Nally, D., Burke, P., Peirce, C., . . . Cunningham, R. M. (2020). Appendicitis and the COVID pandemic; new challenges in the management of a familiar foe. British Journal of Surgery, 107(12), e605-e606. Scopus5 Europe PMC5 |
| 2019 | Beckmann, K., O'Callaghan, M., Vincent, A., Cohen, P., Borg, M., Roder, D., . . . Moretti, K. (2019). Extent and predictors of grade upgrading and downgrading in an Australian cohort according to the new prostate cancer grade groupings.. Asian journal of urology, 6(4), 321-329. Scopus10 WoS10 Europe PMC10 |
| 2019 | Kinnear, N., O'Callaghan, M., Hennessey, D., Liddell, H., Newell, B., Bolt, J., & Lawrentschuk, N. (2019). Intra-operative cell salvage in urological surgery: a systematic review and meta-analysis of comparative studies. BJU International, 123(2), 210-219. Scopus19 WoS17 Europe PMC12 |
| 2019 | Lin, D., O'Callaghan, M. E., David, R., Fuller, A., Wells, R., Sutherland, P., & Foreman, D. (2019). Does urethral length affect continence outcomes following robot assisted laparoscopic radical prostatectomy (RALP)?. |
| 2019 | Forgione, M., Sara, S., Vincent, A. D., Borg, M., Moretti, K., & O'Callaghan, M. E. (2019). Satisfaction with care in men with prostate cancer. European Journal of Cancer Care, 28(4), e13028-1-e13028-8. Scopus6 WoS6 Europe PMC3 |
| 2019 | Ellsworth, J. L., Gingras, J., Smith, L. J., Rubin, H., Seabrook, T. A., Patel, K., . . . Seymour, A. (2019). Clade F AAVHSCs cross the blood brain barrier and transduce the central nervous system in addition to peripheral tissues following intravenous administration in nonhuman primates. PLOS ONE, 14(11), 33 pages. WoS19 |
| 2019 | McMahon, J., Ryan, F., Cannon, M., O'Brien, G., O'Callaghan, M., Flanagan, R., . . . McGorry, P. (2019). Where next for youth mental health services in Ireland?. IRISH JOURNAL OF PSYCHOLOGICAL MEDICINE, 36(3), 163-167. WoS10 |
| 2018 | Ellsworth, J. L., O'Callaghan, M., Rubin, H., & Seymour, A. (2018). Low Seroprevalence of Neutralizing Antibodies Targeting Two Clade F AAV in Humans. HUMAN GENE THERAPY CLINICAL DEVELOPMENT, 29(1), 60-67. WoS11 |
| 2018 | Ellsworth, J. L., O'Callaghan, M., Rubin, H., & Seymour, A. (2018). Low Seroprevalence of Neutralizing Antibodies Targeting Two Clade F AAV in Humans (vol 29, pg 60, 2017). HUMAN GENE THERAPY CLINICAL DEVELOPMENT, 29(2), 113. |
| 2018 | Aref, A., Vincent, A. D., O'Callaghan, M., Martin, S., Sutherland, P., Hoy, A., . . . Wittert, G. (2018). The inverse relationship between prostate specific antigen (PSA) and obesity. Endocrine-Related Cancer, 25(11), 933-941. Scopus23 WoS20 Europe PMC19 |
| 2018 | Neumann, P. B., & O'Callaghan, M. (2018). The role of preoperative puborectal muscle function assessed by transperineal ultrasound in urinary continence outcomes at 3, 6, and 12 months after robotic-assisted radical prostatectomy. International Neurourology Journal, 22(2), 114-122. Scopus15 WoS14 Europe PMC8 |
| 2018 | Burdett, N., Vincent, A., O'Callaghan, M., & Kichenadasse, G. (2018). Competing risks in older patients with cancer: A systematic review of geriatric oncology trials. Journal of the National Cancer Institute, 110(8), 825-830. Scopus36 WoS36 Europe PMC37 |
| 2018 | Lu, T. C., Moretti, K., Beckmann, K., Cohen, P., & O Callaghan, M. (2018). ISUP Group 4 – a Homogenous Group of Prostate Cancers?. Pathology and Oncology Research, 24(4), 921-925. Scopus11 WoS11 Europe PMC8 |
| 2018 | Moretti, K. L., Shi, Z., Kopsaftis, T., & O'Callaghan, M. E. (2018). Delays in radical prostatectomy for prostate cancer and survival outcomes. World journal of urology, 36(8), 1-2. |
| 2018 | Vatandoust, S., Kichenadasse, G., O'Callaghan, M., Vincent, A., Kopsaftis, T., Walsh, S., . . . Moretti, K. (2018). Localized prostate cancer in elderly men aged 80-89, findings from a population-based registry.. BJU international, 121(S3), 48-54. Scopus19 WoS18 Europe PMC13 |
| 2018 | Moretti, K., Vatandoust, S., Kichenadasse, G., O'Callaghan, M. E., Vincent, A. D., Kopsaftis, T., . . . Karapetis, C. (2018). Prostate cancer mortality is high in the elderly and can be reduced by selective individualized curative treatment. World journal of urology, 36(11), 1-2. Scopus1 WoS1 Europe PMC1 |
| 2018 | Beckmann, K., O'Callaghan, M., Vincent, A., Roder, D., Millar, J., Evans, S., . . . Moretti, K. (2018). Australian validation of the Cancer of the Prostate Risk Assessment Post-Surgical score to predict biochemical recurrence after radical prostatectomy. ANZ Journal of Surgery, 88(3), E183-E188. Scopus2 WoS2 Europe PMC2 |
| 2018 | Hoffmann, R., Logan, C., O Callaghan, M., Gormly, K., Chan, K., & Foreman, D. (2018). Does the Prostate Imaging-Reporting and Data System (PI-RADS) version 2 improve accuracy in reporting anterior lesions on multiparametric magnetic resonance imaging (mpMRI)?. International Urology and Nephrology, 50(1), 13-19. Scopus12 WoS9 Europe PMC9 |
| 2017 | Beckmann, K., O'Callaghan, M., Ruseckaite, R., Kinnear, N., Miller, C., Evans, S., . . . Moretti, K. (2017). Prostate cancer outcomes for men who present with symptoms at diagnosis. BJU International, 119(6), 862-871. Scopus6 WoS6 Europe PMC5 |
| 2017 | O'Callaghan, M. E., Shi, Z., Kopsaftis, T., & Moretti, K. (2017). Prostate cancer outcomes and delays in care. International Urology and Nephrology, 49(3), 449-455. Scopus9 WoS9 Europe PMC6 |
| 2017 | Raymond, E., O'Callaghan, M., Campbell, J., Vincent, A., Beckmann, K., Roder, D., . . . Moretti, K. (2017). An appraisal of analytical tools used in predicting clinical outcomes following radiation therapy treatment of men with prostate cancer: a systematic review. Radiation Oncology, 12(1), 56-1-56-20. Scopus15 WoS15 Europe PMC10 |
| 2017 | Campbell, J., O'Callaghan, M., Raymond, E., Vincent, A., Beckmann, K., Roder, D., . . . Moretti, K. (2017). Tools for Predicting Clinical and Patient-reported Outcomes in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy: A Systematic Review of Prognostic Accuracy and Validity. Clinical Genitourinary Cancer, 15(6), 629-634. Scopus7 WoS5 Europe PMC6 |
| 2017 | O'Callaghan, M., Raymond, E., Campbell, J., Vincent, A., Beckmann, K., Roder, D., . . . Moretti, K. (2017). Tools for predicting patient-reported outcomes in prostate cancer patients undergoing radical prostatectomy: A systematic review of prognostic accuracy and validity. Prostate Cancer and Prostatic Diseases, 20(4), 378-388. Scopus21 WoS18 Europe PMC18 |
| 2017 | Campbell, J., Raymond, E., O'Callaghan, M., Vincent, A., Beckmann, K., Roder, D., . . . Moretti, K. (2017). Optimum Tools for Predicting Clinical Outcomes in Prostate Cancer Patients Undergoing Radical Prostatectomy: A Systematic Review of Prognostic Accuracy and Validity. Clinical Genitourinary Cancer, 15(5), e827-e834. Scopus23 WoS22 Europe PMC19 |
| 2017 | O'Callaghan, M. E., Raymond, E., Campbell, J. M., Vincent, A. D., Beckmann, K., Roder, D., . . . Moretti, K. (2017). Patient-reported outcomes after radiation therapy in men with prostate cancer: a systematic review of prognostic tool accuracy and validity. International Journal of Radiation Oncology Biology Physics, 98(2), 318-337. Scopus11 WoS10 Europe PMC8 |
| 2017 | Beckmann, K., Vincent, A., O'Callaghan, M., Cohen, P., Chang, S., Borg, M., . . . Moretti, K. (2017). Oncological outcomes in an Australian cohort according to the new prostate cancer grading groupings. BMC cancer, 17(1), 537. Scopus3 WoS3 Europe PMC2 |
| 2017 | Campbell, J., Raymond, E., O'Callaghan, M., Vincent, A., Beckmann, K., Roder, D., . . . Moretti, K. (2017). Optimum tools for predicting clinical outcomes in prostate cancer patients undergoing radical prostatectomy: a systematic review of prognostic accuracy and validity. Journal of Urology, 197(4), 900. WoS1 |
| 2017 | Mack, D. L., Poulard, K., Goddard, M. A., Latoumerie, V., Snyder, J. M., Grange, R. W., . . . Childers, M. K. (2017). Systemic AAV8-Mediated Gene Therapy Drives Whole-Body Correction of Myotubular Myopathy in Dogs. MOLECULAR THERAPY, 25(4), 839-854. WoS86 |
| 2016 | Ruseckaite, R., Beckmann, K., O'Callaghan, M., Roder, D., Moretti, K., Millar, J., & Evans, S. (2016). A retrospective analysis of Victorian and South Australian clinical registries for prostate cancer: Trends in clinical presentation and management of the disease. BMC Cancer, 16(1), 11 pages. Scopus24 WoS25 Europe PMC20 |
| 2016 | Ruseckaite, R., Beckmann, K., O'Callaghan, M., Roder, D., Moretti, K., Zalcberg, J., . . . Evans, S. (2016). Development of South Australian-Victorian Prostate Cancer Health Outcomes Research Dataset. BMC Research Notes, 9(1), 37. Scopus5 Europe PMC4 |
| 2016 | Ang, M., Rajcic, B., Foreman, D., Moretti, K., & O'Callaghan, M. (2016). Men presenting with prostate-specific antigen (PSA) values of over 100 ng/mL. BJU international, 117(Suppl. 4), 68-75. Scopus26 WoS26 Europe PMC23 |
| 2016 | Kinnear, N., Kichenadasse, G., Plagakis, S., O'Callaghan, M., Kopsaftis, T., Walsh, S., & Foreman, D. (2016). Prostate cancer in men aged less than 50 years at diagnosis. World Journal of Urology, 34(11), 1533-1539. Scopus22 WoS19 Europe PMC19 |
| 2015 | Roberts, R., Miller, M., O'Callaghan, M., & Koczwara, B. (2015). Bone health management of Australian breast cancer survivors receiving hormonal therapy. Internal Medicine Journal, 45(11), 1182-1185. Scopus3 WoS2 Europe PMC2 |
| 2015 | McMichael, G., Bainbridge, M., Haan, E., Corbett, M., Gardner, A., Thompson, S., . . . MacLennan, A. (2015). Whole-exome sequencing points to considerable genetic heterogeneity of cerebral palsy. Molecular Psychiatry, 20(2), 176-182. Scopus194 WoS161 Europe PMC142 |
| 2015 | O'Callaghan, M. (2015). Cancer risk: accuracy of literature. Science, 347(6223), 729. Scopus24 WoS21 Europe PMC22 |
| 2015 | O'Callaghan, M., Kichenadasse, G., Vatandoust, S., & Moretti, K. (2015). Informed decision making about prostate cancer screening. Annals of Internal Medicine, 162(6), 457. Scopus1 WoS1 |
| 2015 | Plagakis, S., Edwards, S., O'Callaghan, M., & Foreman, D. (2015). Predicting bladder cancer death amongst Australian Veterans. Journal of Military and Veterans' Health, 23(1), 4-9. |
| 2014 | Hogan, J., Judge, C., O'Callaghan, M., Aziz, A., O'Connor, C., Burke, J., . . . Coffey, J. C. (2014). Introducing a novel and robust technique for determining lymph node status in colorectal cancer. Annals of Surgery, 260(1), 94-102. Scopus10 Europe PMC7 |
| 2013 | O'Callaghan, M., & MacLennan, A. (2013). Cesarean delivery and cerebral palsy: A systematic review and meta-analysis. Obstetrics and Gynecology, 122(6), 1169-1175. Scopus46 WoS38 Europe PMC32 |
| 2013 | O'Callaghan, M., MacLennan, A., McMichael, G., Haan, E., & Dekker, G. (2013). Single-nucleotide polymorphism associations with preterm delivery: a case-control replication study and meta-analysis. Pediatric Research, 74(4), 433-438. Scopus10 WoS7 Europe PMC5 |
| 2013 | O'Callaghan, M., MacLennan, A., Gibson, C., McMichael, G., Haan, E., Broadbent, J., . . . Dekker, G. (2013). Genetic and clinical contributions to cerebral palsy: A multi-variable analysis. Journal of Paediatrics and Child Health, 49(7), 575-581. Scopus20 WoS10 Europe PMC10 |
| 2013 | O'Callaghan, M., & MacLennan, A. (2013). Brain damage and maternal medication. American Journal of Obstetrics and Gynecology, 208(2), 160-161. |
| 2013 | O'Callaghan, M. (2013). Apolipoprotein E and the genetics of cerebral palsy - where to next?. Developmental Medicine and Child Neurology, 55(4), 302-303. |
| 2013 | Lawlor, M. W., Armstrong, D., Viola, M. G., Widrick, J. J., Meng, H., Grange, R. W., . . . Beggs, A. H. (2013). Enzyme replacement therapy rescues weakness and improves muscle pathology in mice with X-linked myotubular myopathy. HUMAN MOLECULAR GENETICS, 22(8), 1525-1538. WoS57 |
| 2012 | Stefano, J. E., Bird, J., Kyazike, J., Cheng, A. W. -M., Boudanova, E., Dwyer, M., . . . Pan, C. Q. (2012). High-Affinity VEGF Antagonists by Oligomerization of a Minimal Sequence VEGF-Binding Domain. BIOCONJUGATE CHEMISTRY, 23(12), 2354-2364. WoS9 |
| 2012 | Hogg, S. R., Muthu, S., O'Callaghan, M., Lahitte, J. -F., & Bruening, M. L. (2012). Wet Air Oxidation of Formic Acid Using Nanoparticle-Modified Polysulfone Hollow Fibers as Gas-Liquid Contactors. ACS APPLIED MATERIALS & INTERFACES, 4(3), 1440-1448. WoS6 |
| 2012 | O'Callaghan, M., MacLennan, A., Gibson, C., McMichael, G., Haan, E., Broadbent, J., . . . Dekker, G. (2012). Fetal and maternal candidate single nucleotide polymorphism associations with Cerebral Palsy: a case-control study. Pediatrics, 129(2), E414-E423. Scopus33 WoS23 Europe PMC23 |
| 2011 | O'Callaghan, M., MacLennan, A., Gibson, C., McMichael, G., Haan, E., Broadbent, J., . . . Dekker, G. (2011). Epidemiologic associations with cerebral palsy. Obstetrics and Gynecology, 118(3), 576-582. Scopus99 WoS89 Europe PMC71 |
| 2011 | McMichael, G., Highet, A., Gibson, C., Goldwater, P., O'Callaghan, M., Alvino, E., & MacLennan, A. (2011). Comparison of DNA extraction methods from small samples of newborn screening cards suitable for retrospective perinatal viral research. Journal of Biomolecular Techniques, 22(1), 5-9. Scopus8 Europe PMC4 |
| 2011 | O'Callaghan, M., MacLennan, A., Gibson, C., McMichael, G., Haan, E., Broadbent, J., . . . Dekker, G. (2011). The Australian cerebral palsy research study - Protocol for a national collaborative study investigating genomic and clinical associations with cerebral palsy. Journal of Paediatrics and Child Health, 47(3), 99-110. Scopus12 WoS10 Europe PMC8 |
| 2010 | Kremmidiotis, G., Leske, A., Lavranos, T., Beaumont, D., Gasic, J., Hall, A., . . . Flynn, B. (2010). BNC105: a novel tubulin polymerization inhibitor that selectively disrupts tumor vasculature and displays single-agent antitumor efficacy. Molecular Cancer Therapeutics, 9(6), 1562-1573. Scopus79 WoS72 Europe PMC60 |
| 2010 | Piepenhagen, P. A., Vanpatten, S., Hughes, H., Waire, J., Murray, J., Andrews, L., . . . Thurberg, B. L. (2010). Use of Direct Fluorescence Labeling and Confocal Microscopy to Determine the Biodistribution of Two Protein Therapeutics, Cerezyme® and Ceredase®. MICROSCOPY RESEARCH AND TECHNIQUE, 73(7), 694-703. WoS9 |
| 2010 | Westrich, J., Yaeger, P., He, C., Stewart, J., Chen, R., Seleznik, G., . . . Molnar, G. (2010). Factors Affecting Residence Time of Mesenchymal Stromal Cells (MSC) Injected Into the Myocardium. CELL TRANSPLANTATION, 19(8), 937-948. WoS33 |
| 2009 | McMichael, G., Gibson, C., O'Callaghan, M., Goldwater, P., Dekker, G., Haan, E., & MacLennan, A. (2009). DNA from Buccal Swabs Suitable for High-Throughput SNP Multiplex Analysis. Journal of Biomolecular Techniques, 20(5), 232-235. Scopus33 Europe PMC25 |
| 2009 | O'Callaghan, M., MacLennan, A., Haan, E., & Dekker, G. (2009). The genomic basis of cerebral palsy: A HuGE systematic literature review. Human Genetics, 126(1), 149-172. Scopus51 WoS39 Europe PMC38 |
| 2008 | Scott, J., Welham, J., Martin, G., Bor, W., Najman, J., O'Callaghan, M., . . . McGrath, J. (2008). Demographic correlates of psychotic-like experiences in young Australian adults. ACTA PSYCHIATRICA SCANDINAVICA, 118(3), 230-237. WoS88 |
| 2008 | McVie-Wylie, A. J., Lee, K. L., Qiu, H., Jin, X., Do, H., Gotschall, R., . . . Mattaliano, R. (2008). Biochemical and pharmacological characterization of different recombinant acid α-glucosidase preparations evaluated for the treatment of Pompe disease. MOLECULAR GENETICS AND METABOLISM, 94(4), 448-455. WoS80 |
| 2008 | O'Callaghan, M., & Gordon, G. N. G. (2008). An individual-based stochastic hazard model of eastern king prawn (<i>Melicertus plebejus</i>) migration with spatially and temporally varying fishing effort. ECOLOGICAL MODELLING, 218(1-2), 73-94. WoS9 |
| 2006 | Thurberg, B. L., Maloney, C. L., Vaccaro, C., Afonso, K., Tsai, A. C. -H., Bossen, E. H., . . . O'Callaghan, M. (2006). Characterization of pre- and post-treatment pathology after enzyme replacement therapy for pompe disease. LABORATORY INVESTIGATION, 86(12), 1208-1220. WoS222 |
| 2005 | Murray, A. G., & O'Callaghan, M. (2005). The numerical and programming methods used to implement models of the spread and impact of a major epidemic disease: pilchard herpesvirus, Australia 1995 and 1998/1999. ENVIRONMENTAL MODELLING & SOFTWARE, 20(5), 575-585. WoS6 |
| 2005 | O'Callaghan, M., Reddin, J., & Lehmann, D. (2005). Helminth and protozoan parasites of feral cats from Kangaroo Island. TRANSACTIONS OF THE ROYAL SOCIETY OF SOUTH AUSTRALIA, 129, 81-83. WoS15 |
| 2004 | Najman, J. M., Aird, R., Bor, W., O'Callaghan, M., Williams, G. M., & Shuttlewood, G. J. (2004). The generational transmission of socioeconomic inequalities in child cognitive development and emotional health. SOCIAL SCIENCE & MEDICINE, 58(6), 1147-1158. WoS126 |
| 2004 | Burns, Y., O'Callaghan, M., McDonell, B., & Rogers, Y. (2004). Movement and motor development in ELBW infants at 1 year is related to cognitive and motor abilities at 4 years. EARLY HUMAN DEVELOPMENT, 80(1), 19-29. WoS52 |
| 2003 | Murray, A. G., O'Callaghan, M., & Jones, B. (2003). A model of spatially evolving herpesvirus epidemics causing mass mortality in Australian pilchard <i>Sardinops sagax</i>. DISEASES OF AQUATIC ORGANISMS, 54(1), 1-14. WoS28 |
| 2003 | Bor, W., Brennan, P. A., Williams, G. M., Najman, J. M., & O'Callaghan, M. (2003). A mother's attitude towards her infant and child behaviour five years later. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 37(6), 748-755. WoS17 |
| 2002 | O'Callaghan, M., & Murray, A. G. (2002). A tractable deterministic model with realistic latent period for an epidemic in a linear habitat. JOURNAL OF MATHEMATICAL BIOLOGY, 44(3), 227-251. WoS4 |
| 2001 | Murray, A. G., O'Callaghan, M., & Jones, B. (2001). A model of transmission of a viral epidemic among schools within a shoal of pilchards. ECOLOGICAL MODELLING, 144(2-3), 245-259. WoS15 |
| 2001 | Najman, J. M., Williams, G. M., Nikles, J., Spence, S., Bor, W., O'Callaghan, M., . . . Shuttlewood, G. J. (2001). Bias influencing maternal reports of child behaviour and emotional state. SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY, 36(4), 186-194. WoS247 |
| 1997 | Creme, G. A., Walsh, P. M., O'Callaghan, M., & Kelly, T. C. (1997). The changing status of the lesser black-backed gull Larus fuscus in Ireland. BIOLOGY AND ENVIRONMENT-PROCEEDINGS OF THE ROYAL IRISH ACADEMY, 97B(2), 149-156. WoS2 |
| Year | Citation |
|---|---|
| 2025 | Livingston, P. M., Winter, N., Russell, L., Eric, O., Smith, A. B., Romaniuk, H., . . . White, V. M. (2025). Efficacy of an online mindfulness program (MindOnLine) to reduce fear of recurrence in people living with–and beyond–breast, prostate or colorectal cancer: a randomized controlled trial. In Eclinicalmedicine Vol. 86 (pp. 13 pages). ELSEVIER. DOI |
| 2023 | Schultz, M., Durr, A., Karachi, C., O'Callaghan, M., Alves, S., Lamontagne, A., . . . Cartier, N. (2023). Investigating the Effects of Brain Cholesterol Metabolism Using CYP46A1 Gene Therapy in Subjects with Huntington's Disease. In NEUROLOGY Vol. 100 (pp. 3 pages). MA, Boston: LIPPINCOTT WILLIAMS & WILKINS. DOI WoS1 |
| 2023 | Subashi, E., Yousef-Zadeh, H., Cottin, S., Kemp, D., Lamontagne, A., O'Callaghan, M., . . . Cartier, N. (2023). Restoration of Brain Cholesterol Metabolism as Gene Therapy Strategy in Huntington's Disease: Unilateral Injections Are Insufficient to Elicit a Treatment Effect in HD Mice. In MOLECULAR THERAPY Vol. 31 (pp. 598-599). CELL PRESS. |
| 2022 | Henry, T., Chung, E., Traverse, J., Reynolds, K., Alvisi, M., Ervin, L., . . . Hajjar, R. (2022). A First-in-Human Phase 1 Clinical Gene Therapy Trial for the Treatment of Heart Failure Using a Novel Re-Engineered Adeno-Associated Vector. In MOLECULAR THERAPY Vol. 30 (pp. 14-15). CELL PRESS. WoS4 |
| 2022 | Tempo, J., O'Callaghan, M., & Bolton, D. (2022). A global review of bladder cancer mortality in the elderly. In INTERNATIONAL JOURNAL OF UROLOGY Vol. 29 (pp. 122). WILEY. |
| 2022 | Tempo, J., O'Callaghan, M., & Bolton, D. (2022). Exploring South Australia's decreasing bladder cancer survival. In INTERNATIONAL JOURNAL OF UROLOGY Vol. 29 (pp. 122-123). WILEY. |
| 2022 | David, R., & O'Callaghan, M. (2022). Ten-year cumulative incidence and burden associated with treatment-related toxicity in men with localised prostate cancer. In INTERNATIONAL JOURNAL OF UROLOGY Vol. 29 (pp. 105). WILEY. |
| 2022 | David, R., & O'Callaghan, M. (2022). Comparison of patient-reported outcomes measures in patients with localised prostate cancer following external beam radiotherapy or radical prostatectomy. In INTERNATIONAL JOURNAL OF UROLOGY Vol. 29 (pp. 105-106). WILEY. |
| 2022 | John, A., Lim, A., Catterwell, R., Seth, L., & O'Callaghan, M. (2022). Does size matter? Extension of positive surgical margins after radical prostatectomy - a systematic review and meta-analysis. In EUROPEAN UROLOGY Vol. 81 (pp. S258). ELSEVIER. DOI |
| 2022 | O'Callaghan, M., Roberts, M., Grummet, J., Mark, S., Gilbourd, D., Frydenberg, M., . . . Papa, N. (2022). Population-wide trends and variation in prostate cancer diagnosis via transperineal biopsy. In BJU INTERNATIONAL Vol. 129 (pp. 157). Gold Coast, AUSTRALIA: WILEY. |
| 2022 | Tiruye, T., O'Callaghan, M., Moretti, K., Jay, A., Higgs, B., Santoro, K., . . . Beckmann, K. (2022). Patient-reported functional outcome measures at baseline and 12 months post-treatment and their association with treatment choice for prostate cancer. In BJU INTERNATIONAL Vol. 129 (pp. 19). Gold Coast, AUSTRALIA: WILEY. |
| 2022 | Wei, G., Harley, F., O'Callaghan, M., Adshead, J., Hennessey, D., & Kinnear, N. (2022). A systematic review of bladder and ureteric injury during caesarean section and hysterectomy; incidence, risk factors and prevention. In BJU INTERNATIONAL Vol. 129 (pp. 13-14). Gold Coast, AUSTRALIA: WILEY. |
| 2022 | Harley, F., Wei, G., O'Callaghan, M., Wong, L. -M., Hennessey, D., & Kinnear, N. (2022). Demographics, treatment, and mortality of 1,139 cases of xanthogranulomatous pyelonephritis; a systematic review. In BJU INTERNATIONAL Vol. 129 (pp. 55-56). Gold Coast, AUSTRALIA: WILEY. |
| 2022 | John, A., Catterwell, R., Lim, A., Selth, L., & O'Callaghan, M. (2022). Extension of positive surgical margins after radical prostatectomy: Does size matter? - A systematic review and meta-analysis. In BJU INTERNATIONAL Vol. 129 (pp. 139). Gold Coast, AUSTRALIA: WILEY. |
| 2022 | John, A., Milton, T., Gupta, A., Stretton, B., Hewitt, J., Catteerwell, R., . . . O'Callaghan, M. (2022). Location of positive surgical margins after radical prostatectomy- A systematic review and network meta-analysis. In BJU INTERNATIONAL Vol. 129 (pp. 26-27). Gold Coast, AUSTRALIA: WILEY. |
| 2022 | John, A., Milton, T., Gupta, A., Nguyen, M., Stretton, B., Hewitt, J., . . . O'Callaghan, M. (2022). Does location of positive surgical margins after radical prostatectomy matter?-A systematic review and network meta-analysis. In INTERNATIONAL JOURNAL OF UROLOGY Vol. 29 (pp. 13-14). WILEY. |
| 2022 | Doolette, I., Jay, A., Pathi, R., Ayres, O., O'Callaghan, M., Bodda, S., . . . Williams, G. (2022). Survival and peri-operative safety outcomes of thermal ablation versus partial nephrectomy for cT1 renal cell cancer at an Australian tertiary institution. In BJU INTERNATIONAL Vol. 129 (pp. 54-55). Gold Coast, AUSTRALIA: WILEY. |
| 2022 | David, R., Buckby, A., Kahokehr, A., Lee, J., Watson, D., Leung, J., & Ocallaghan, M. (2022). Predicting genitourinary toxicity after radiotherapy treatment for localised prostate cancer. In BJU INTERNATIONAL Vol. 129 (pp. 24-25). Gold Coast, AUSTRALIA: WILEY. |
| 2021 | Liang, H., Hunt, J. B., Ma, C., Rocha-Rangel, P. V., O'Callaghan, M., Quadri, Z., . . . Lee, D. C. (2021). Understanding Tau Citrullination During Tauopathies and Related Dementias. In CELL TRANSPLANTATION Vol. 30 (pp. 11). SAGE PUBLICATIONS INC. WoS1 |
| 2020 | Kinnear, N., Barnett, D., O'Callaghan, M., Horsell, K., Gani, J., & Hennessey, D. (2020). The impact of catheter-based bladder drainage method on urinary tract infection risk in neurogenic bladder; a systematic review. In BJU INTERNATIONAL Vol. 125 (pp. 10). Sydney, AUSTRALIA: WILEY. |
| 2019 | O'Callaghan, M. (2019). Prostate cancer screening: Confusion, controversy and enlightenment. In ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY Vol. 15 (pp. 97-98). WILEY. |
| 2019 | Beckman, K., O'Callaghan, M., Moretti, K., Vincent, A., & Brook, N. (2019). Clinical and pathological factors associated with positive surgical margins in patients undergoing radical prostatectomy from the SA-PCCOC. In BJU INTERNATIONAL Vol. 123 (pp. 69-70). Brisbane, AUSTRALIA: WILEY. |
| 2019 | Shepherd, A., O'Callaghan, M., & Sutherland, P. (2019). Does eligibility for active surveillance of prostate cancer affect functional outcomes after radical prostatectomy?. In BJU INTERNATIONAL Vol. 123 (pp. 51). Brisbane, AUSTRALIA: WILEY. |
| 2019 | Forgione, M., Sara, S., Vincent, A. D., Borg, M., Moretti, K., & O'Callaghan, M. E. (2019). Satisfaction with care in men with prostate cancer. In Abstracts of the 2nd Prostate Cancer World Congress (PCWC 2015), as published in BJU International Vol. 116 (pp. 22-23). Cairns, AUSTRALIA: Wiley. DOI |
| 2017 | Li, M., Osei-Tutu, L., Lee, J., & O'Callaghan, M. (2017). CT scan for prostate cancer staging - Prevalence of incidentalomas and does it affect management?. In BJU INTERNATIONAL Vol. 120 (pp. 25-26). MALAYSIA: WILEY. WoS1 |
| 2017 | Das, K., Ordones, F. V., Fuller, A., O'Callaghan, M., & Brook, N. R. (2017). COMPARISON OF ONCOLOGICAL AND FUNCTIONAL OUTCOMES FOLLOWING RADICAL PROSTATECTOMY IN CLINICAL T2 AND CLINICAL T3 PROSTATE CANCERS: FINDINGS FROM THE SA-PCOCC DATABASE.. In JOURNAL OF UROLOGY Vol. 197 (pp. E631). Boston, MA: ELSEVIER SCIENCE INC. DOI |
| 2017 | Ellsworth, J. L., Smith, L., Rubin, H., Seymour, A., Morales, P., Chlipala, E., & O'Callaghan, M. (2017). Widespread Transduction of the Central Nervous System Following Systemic Delivery of AAVHSC17 in Non-Human Primates. In MOLECULAR THERAPY Vol. 25 (pp. 262). DC, Washington: CELL PRESS. WoS1 |
| 2017 | Ellsworth, J. L., Rubin, H., Seymour, A., & O'Callaghan, M. (2017). Prevalence of Neutralizing Antibodies Targeting Two Novel Clade F AAV in Human Sera. In MOLECULAR THERAPY Vol. 25 (pp. 89). DC, Washington: CELL PRESS. |
| 2016 | Nag, N., Kedda, M. -A., Gourlay, C., Sampurno, F., O'Callaghan, M., Teuss, S., . . . Evans, S. M. (2016). Towards national reporting on prostate cancer care. In BJU INTERNATIONAL Vol. 118 (pp. 8). Melbourne, AUSTRALIA: WILEY-BLACKWELL. |
| 2016 | Shepherd, A., Beckmann, K., & O'Callaghan, M. (2016). Clinical outcomes for rural patients with prostate cancer in South Australia. In BJU INTERNATIONAL Vol. 117 (pp. 106-107). Gold Coast, AUSTRALIA: WILEY-BLACKWELL. |
| 2016 | Mathur, N., Beckmann, K., Moretti, K., Kopsaftis, T., D'Onise, K., Walsh, S., & O'Callaghan, M. (2016). A review of the incidence, management and prognosis of the ductal subtype of prostate cancer. In BJU INTERNATIONAL Vol. 117 (pp. 97-98). Gold Coast, AUSTRALIA: WILEY-BLACKWELL. |
| 2016 | Beckmann, K., O'Callaghan, M., Vincent, A., Ruseckaite, R., Roder, D., Evans, A. S., & Moretti, K. (2016). Application of International Society of Urological Pathology's (ISUP) new grade categories for prostate cancer: outcomes and upgrading in South Australia (SA). In BJU INTERNATIONAL Vol. 117 (pp. 35-36). Gold Coast, AUSTRALIA: WILEY-BLACKWELL. |
| 2016 | Beckmann, K., Vincent, A., O'Callaghan, M., Sampurno, F., Ruseckaite, R., Evans, S., . . . Moretti, K. (2016). Oncological outcomes in an Australian cohort according to the new International Society of Urological Pathology (ISUP-2014) prostate cancer grading categories. In BJU INTERNATIONAL Vol. 118 (pp. 16-17). Melbourne, AUSTRALIA: WILEY-BLACKWELL. |
| 2015 | Ang, M., Rajic, B., Foreman, D., & O'Callaghan, M. (2015). Men presenting with prostate specific antigen (PSA) levels over 100 ng/mL at the time of diagnosis. In BJU INTERNATIONAL Vol. 116 (pp. 23). Cairns, AUSTRALIA: WILEY-BLACKWELL. |
| 2015 | O'Callaghan, M., Shi, Z., Walsh, S., Kopsaftis, T., & Moretti, K. (2015). Delays in prostate cancer treatment following diagnosis. In BJU INTERNATIONAL Vol. 116 (pp. 21-22). Cairns, AUSTRALIA: WILEY-BLACKWELL. |
| 2015 | Beckmann, K., O'Callaghan, M., Ruseckaite, R., Moretti, K., Evans, S., Millar, J., . . . Roder, D. (2015). The changing profile of prostate cancer in South Australia. In BJU INTERNATIONAL Vol. 116 (pp. 20-21). Cairns, AUSTRALIA: WILEY-BLACKWELL. |
| 2015 | Shepherd, A., & O'Callaghan, M. (2015). Eligibility for active surveillance of prostate cancer and functional outcomes after prostatectomy. In BJU INTERNATIONAL Vol. 115 (pp. 33). Adelaide, AUSTRALIA: WILEY-BLACKWELL. |
| 2015 | Mack, D., Poulard, K., Goddard, M., Snyder, J., Grange, R., Doering, J., . . . Buj-Bello, A. (2015). Peripheral vein injection of AAV8-MTM1 leads to long-term survival and correction of severe muscle pathology in a canine model of X-linked myotubular myopathy: Results from a dose escalation study. In NEUROMUSCULAR DISORDERS Vol. 25 (pp. S274). ENGLAND, Brighton: PERGAMON-ELSEVIER SCIENCE LTD. DOI |
| 2015 | Mack, D. L., Poulard, K., Goddard, M., Snyder, J. M., Grange, R. W., Doering, J., . . . Childers, M. K. (2015). Minimally Effective Dose of Systemic AAV8-MTM1 Needed To Prolong Survival and Correct Severe Muscle Pathology in a Canine Model of X-Linked Myotubular Myopathy. In MOLECULAR THERAPY Vol. 23 (pp. S201). LA, New Orleans: NATURE PUBLISHING GROUP. DOI |
| 2015 | Lawlor, M., Mack, D., Poulard, K., Goddard, M., Snyder, J., Grange, R., . . . Childers, M. (2015). AAV8-MTM1 results in long-term survival and correction of severe muscle pathology in a canine model of X-linked myotubular myopathy. In JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY Vol. 74 (pp. 617). CO, Denver: LIPPINCOTT WILLIAMS & WILKINS. |
| 2014 | Mack, D. L., Goddard, M., Snyder, J. M., Doering, J., Lawlor, M. W., Moullier, P., . . . Childers, M. (2014). Canine X-linked myotubular myopathy: A dose-finding study of systemic AAV8-MTM1 effects on muscle strength, gait, respiration, neuromuscular function and survival. In NEUROMUSCULAR DISORDERS Vol. 24 (pp. 807). GERMANY, Berlin: PERGAMON-ELSEVIER SCIENCE LTD. DOI |
| 2014 | Mack, D. L., Goddard, M., Snyder, J. M., Grange, R. W., Doering, J. A., Lawlor, M. W., . . . Childers, M. K. (2014). Dose-Response Effects Following Systemic Infusion of AAV8-MTM1 on Muscle Strength, Walking Speed, Respiration, Neuromuscular Function and Survival in a Canine Model of X-Linked Myotubular Myopathy. In MOLECULAR THERAPY Vol. 22 (pp. S198-S199). DC, Washington: CELL PRESS. |
| 2014 | Roberts, R., Miller, M., O'Callaghan, M., & Koczwara, B. (2014). BONE HEALTH MANAGEMENT OF BREAST AND PROSTATE CANCER SURVIVORS RECEIVING HORMONAL THERAPY. In ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY Vol. 10 (pp. 165). WILEY-BLACKWELL. |
| 2014 | O'Callaghan, M., Pinnock, C., Hall, K., Walsh, S., Kopsaftis, T., & Moretti, K. (2014). Prostate cancer recurrence and delays in care following an elevated PSA. In BJU INTERNATIONAL Vol. 113 (pp. 38). Brisbane, AUSTRALIA: WILEY-BLACKWELL. |
| 2013 | Lannon, R., O'Callaghan, M., Steen, G., Casey, M. C., & Walsh, J. B. (2013). The Role of IV Bisphosphonates in Relation to Denosumab. In IRISH JOURNAL OF MEDICAL SCIENCE Vol. 182 (pp. S259). SPRINGER LONDON LTD. |
| 2013 | Lannon, R., O'Callaghan, M., Fallon, N., Casey, M., & Walsh, J. B. (2013). Denosumab is here - do intravenous bisphosphonates still have a role?. In JOURNAL OF BONE AND MINERAL RESEARCH Vol. 28 (pp. 3 pages). MD, Baltimore: WILEY-BLACKWELL. |
| 2012 | Suresh, S., Mamun, A., O'Callaghan, M., & Sly, P. D. (2012). IMPACT OF CATCH-UP GROWTH AND BODY MASS INDEX DURING CHILDHOOD ON LUNG FUNCTION AT 21 YEARS. In RESPIROLOGY Vol. 17 (pp. 77). WILEY-BLACKWELL. |
| 2010 | Cheng, W., Stefano, J., Li, D., Kyazike, J., Boudanova, K., Qiu, H., . . . Matthews, G. (2010). CHARACTERIZATION OF SUSTAINED RELEASE NATIVE AND MODIFIED HUMAN SFLT01 FORMULATION FOR INTRAARTICULAR DELIVERY TO TREAT OA PAIN. In OSTEOARTHRITIS AND CARTILAGE Vol. 18 (pp. S240-S241). BELGIUM, Brussels: W B SAUNDERS CO LTD. DOI |
| 2010 | O'Callaghan, M. E., MacLennan, A. H., Goldwater, P. N., McMichael, G., & et al. (2010). Australian Collaborative Study of genomic and environmental factors associated with CP. In Conference Proceedings. Sydney, Australia. |
| 2008 | McPherson, L., Lennox, N., Bain, C., Carrington, S., Williams, G., & O'Callaghan, M. (2008). Recruitment and retention difficulties in a RCT involving adolescents with intellectual disability. In JOURNAL OF INTELLECTUAL DISABILITY RESEARCH Vol. 52 (pp. 750). WILEY-BLACKWELL. |
| 2008 | Fitzgerald, A. A., O'Callaghan, M., Magid, D. J., Clarke, C., Brand, D., Peterson, P. N., & Masoudi, F. (2008). Comparing administrative coding algorithms in identifying patients with heart failure. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 51 (pp. A241). IL, Chicago: ELSEVIER SCIENCE INC. |
| 2008 | Thurberg, B., Rennke, H., Colvin, R., Dikman, S., Gordon, R., & O'Callaghan, M. (2008). Pathology of Fabry nephropathy: Renal fibrosis may begin in adolescence. In MOLECULAR GENETICS AND METABOLISM Vol. 93 (pp. S39). NV, Las Vegas: ACADEMIC PRESS INC ELSEVIER SCIENCE. WoS2 |
| 2007 | Wentworth, B., Stewart, J., Westrich, J., He, C., Blaksvedt, A., Akita, G., . . . Yaeger, P. (2007). Studies on the retention of cells delivered to the rat heart. In EUROPEAN HEART JOURNAL Vol. 28 (pp. 231). OXFORD UNIV PRESS. |
| 2006 | Li, P., Raitcheva, D., Moran, N., Burns, J., O'Callaghan, M., & Matthews, G. L. (2006). Hylan treatment inhibits IL-1β mediated production of PGE2 in chondrocytes and synoviocytes by regulating COX-2 expression.. In JOURNAL OF BONE AND MINERAL RESEARCH Vol. 21 (pp. S129). PA, Philadelphia: AMER SOC BONE & MINERAL RES. |
| 2003 | O'Callaghan, F., O'Callaghan, M., Najman, J., Williams, G. M., & Bor, W. (2003). Maternal alcohol consumption during pregnancy and physical outcomes up to 5 years of age: A longitudinal study. In AUSTRALIAN JOURNAL OF PSYCHOLOGY Vol. 55 (pp. 200-201). AUSTRALIAN PSYCHOLOGICAL SOC. |
| 2001 | Murray, A. G., O'Callaghan, M., & Jones, B. (2001). Simple models of massive epidemics of herpesvirus in Australian (and New Zealand) pilchards. In ENVIRONMENT INTERNATIONAL Vol. 27 (pp. 243-248). NEW ZEALAND, HAMILTON: PERGAMON-ELSEVIER SCIENCE LTD. DOI WoS22 |
| - | Lennox, N., Bain, C., Carrington, S., O'Callaghan, M., McPherson, L., & Ware, R. (n.d.). Improving health advocacy and health outcomes in adolescents with intellectual disabilities. In JOURNAL OF INTELLECTUAL DISABILITY RESEARCH Vol. 60 (pp. 695). WILEY-BLACKWELL. |
| Year | Citation |
|---|---|
| 2025 | Charlick, M., Tiruye, T., Ettridge, K., O'Callaghan, M., Sara, S., Jay, A., & Beckmann, K. (2025). Sexual wellbeing support for men with prostate cancer: challenges and areas of change. Poster session presented at the meeting of BJU International. UK: Wiley-Blackwell Publishing. |
| 2022 | O'Callaghan, M., Roberts, M., Moretti, K., Frydenberg, M., Gilbourd, D., Mark, S., . . . Papa, N. (2022). Variation in patient reported outcomes following radical prostatectomy: A bi-national registry based study. Poster session presented at the meeting of INTERNATIONAL JOURNAL OF UROLOGY. WILEY. |
| 2017 | Lin, D., Plagakis, S., O'Callaghan, M., Neumann, P., Fuller, A., Wells, R., . . . Foreman, D. (2017). Does age, BMI or prostate volume affect continence outcomes following robot assisted laparoscopic radical prostatectomy (RALP)?. Poster session presented at the meeting of BJU INTERNATIONAL. Canberra, AUSTRALIA: WILEY-BLACKWELL. DOI |
| 2017 | Aref, A. T., Vincent, A., O'Callaghan, M., Hoy, A., Butler, L., & Wittert, G. (2017). The inverse relationship between prostate specific antigen (PSA) and obesity in healthy men; support for a hormonal, rather than haemodilution mechanism. Poster session presented at the meeting of Abstracts of the 2017 ANZUP Annual Scientific Meeting, as published in Asia-Pacific Journal Of Clinical Oncology. Melbourne, VIC: Wiley. DOI |
| 2016 | Neumann, P., O'Callaghan, M., Foreman, D., Plagakis, S., Sutherland, P., Fuller, A., & Wells, R. (2016). Bladder neck displacement and continence outcomes within 12 months of robot assisted radical prostatectomy (RARP). Poster session presented at the meeting of BJU INTERNATIONAL. Melbourne, AUSTRALIA: WILEY-BLACKWELL. |
| 2016 | Plagakis, S., O'Callaghan, M., Neumann, P., Fuller, A., Wells, R., Sutherland, P., & Foreman, D. (2016). Age does not affect continence outcome following robot assisted laparoscopic radical prostatectomy (RALP). Poster session presented at the meeting of BJU INTERNATIONAL. Melbourne, AUSTRALIA: WILEY-BLACKWELL. |
| 2015 | Vatandoust, S., Kichenadasse, G., O'Callaghan, M. E., Kopsaftis, T., Walsh, S., Borg, M., . . . Moretti, K. L. (2015). Antiandrogen withdrawal (AAWD) in patients (pts) with prostate cancer (PCa): Retrospective analysis of data from the South Australian Prostate Cancer Clinical Outcome Collaborative (SA-PCCOC).. Poster session presented at the meeting of JOURNAL OF CLINICAL ONCOLOGY. Orlando, FL: AMER SOC CLINICAL ONCOLOGY. DOI WoS1 |
| 2015 | Ruseckaite, R., Beckman, K., O'Callaghan, M., Roder, D., Moretti, K., Millar, J., . . . Evans, S. (2015). A retrospective analysis of South Australian and Victorian clinical registries for prostate cancer. Poster session presented at the meeting of BJU INTERNATIONAL. Cairns, AUSTRALIA: WILEY-BLACKWELL. |
| 2014 | Foreman, D., Plagakis, S., Edwards, S., & O'Callaghan, M. (2014). How does T and N stage affect survival following cystectomy for transitional cell cancer of the bladder in a South Australian population?. Poster session presented at the meeting of Abstracts of the 67th Annual Scientific Meeting of the Urological Society of Australia and New Zealand, as published in BJU International. Brisbane, Australia: Wiley-Blackwell. DOI |
| Year | Citation |
|---|---|
| 2025 | Livingston, P., Winter, N., Russell, L., O, E., Romaniuk, H., Jefford, M., . . . White, V. M. (2025). Efficacy of an Online Mindfulness Program (MindOnLine) to Reduce Fear of Recurrence in People Living with and Beyond, Breast, Prostate or Colorectal Cancer: A Randomized Controlled Trial. DOI |
| 2022 | McIntosh, M., Opozda, M. J., O’Callaghan, M., Vincent, A. D., Galvão, D. A., & Short, C. E. (2022). Impact of different unconditional monetary incentives on survey response rates in men with prostate cancer: a 2-arm SWAT. DOI |
| 2020 | Tran, M. D., Moretti, K. L., & O'Callaghan, M. E. (2020). Time to Prostate-Specific Antigen Nadir After Radical Prostatectomy – a new potential predictive prognostic parameter and its impact on clinical outcomes. DOI |
| Date | Role | Research Topic | Program | Degree Type | Student Load | Student Name |
|---|---|---|---|---|---|---|
| 2023 | Principal Supervisor | Defining and describing different clinical phenotypes of local and metastatic prostate cancer using Prostate Specific Membrane Antigen PET | Doctor of Philosophy | Doctorate | Part Time | Dr Mrunal Devendra Hiwase |
| 2023 | Principal Supervisor | Defining and describing different clinical phenotypes of local and metastatic prostate cancer using Prostate Specific Membrane Antigen PET | Doctor of Philosophy | Doctorate | Full Time | Dr Mrunal Devendra Hiwase |
| 2021 | Principal Supervisor | Pathological parameters of positive surgical margins | Doctor of Philosophy | Doctorate | Part Time | Dr Athul Francis John |
| 2021 | Principal Supervisor | Pathological parameters of positive surgical margins | Doctor of Philosophy | Doctorate | Full Time | Dr Athul Francis John |
| Date | Role | Research Topic | Program | Degree Type | Student Load | Student Name |
|---|---|---|---|---|---|---|
| 2016 - 2019 | Co-Supervisor | Defining the Role of Lipids and Metabolic Factors as Risk Factors for Prostate Cancer Incidence and Aggressiveness | Doctor of Philosophy | Doctorate | Full Time | Dr Adel Aref |
| Date | Role | Committee | Institution | Country |
|---|---|---|---|---|
| 2020 - ongoing | Member | Steering Committee of the South Australian Clinical Cancer Registry | South Australian Clinical Cancer | Australia |
| 2019 - ongoing | Member | Radiation Oncology Quality Indicator Working Group | Prostate Cancer Outcomes Registry Australia and New Zealand | Australia |
| 2018 - ongoing | Member | Prostate Cancer Symposium | South Australian Prostate Cancer Clinical Outcomes Collaborative | Australia |
| 2017 - ongoing | Member | Prostate Cancer Symposium | South Australian Prostate Cancer Clinical Outcomes Collaborative | Australia |
| 2017 - 2017 | Chair | Clinical Registries Oral Presentation Session, Flinders Health Research Week, | Flinders Medical Centre | Australia |
| 2017 - ongoing | Member | Surgical Quality Indicator Working Group | Prostate Cancer Outcomes Registry Australia and New Zealand | Australia |
| Date | Role | Membership | Country |
|---|---|---|---|
| 2014 - ongoing | Member | Urological Society of Australia and New Zealand, | Australia |
| 2014 - ongoing | Member | Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group | Australia |
| 2014 - ongoing | Member | Freemasons Foundation Centre for Men’s Health | Australia |
Connect With Me
External Profiles
